APA (7th ed.) Citation

Cummings, J., Isaacson, S., Mills, R., Williams, H., Chi-Burris, K., Dhall, R., & Ballard, C. (2013). Antipsychotic efficacy and motor tolerability in a phase III placebo-controlled study of pimavanserin in patients with Parkinson's Disease psychosis (Acp-103-020). Journal of the Neurological Sciences, 333, e119. https://doi.org/10.1016/j.jns.2013.07.401

Chicago Style (17th ed.) Citation

Cummings, J., S. Isaacson, R. Mills, H. Williams, K. Chi-Burris, R. Dhall, and C. Ballard. "Antipsychotic Efficacy and Motor Tolerability in a Phase III Placebo-controlled Study of Pimavanserin in Patients with Parkinson's Disease Psychosis (Acp-103-020)." Journal of the Neurological Sciences 333 (2013): e119. https://doi.org/10.1016/j.jns.2013.07.401.

MLA (9th ed.) Citation

Cummings, J., et al. "Antipsychotic Efficacy and Motor Tolerability in a Phase III Placebo-controlled Study of Pimavanserin in Patients with Parkinson's Disease Psychosis (Acp-103-020)." Journal of the Neurological Sciences, vol. 333, 2013, p. e119, https://doi.org/10.1016/j.jns.2013.07.401.